Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL
Conditions
- Non Hodgkin Lymphoma
- Follicular Lymphoma
- Relapsed Follicular Lymphoma
Interventions
- DRUG: 10 MBq/kg Betalutin
- DRUG: 15 MBq/kg Betalutin
Sponsor
Nordic Nanovector
Collaborators